NYMOX PHARMACEUTICAL CORPORATION Profit Loss From Operating Activities
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Profit Loss From Operating Activities of -$4.28 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:ProfitLossFromOperatingActivities · last filed 2025-06-03
- NYMOX PHARMACEUTICAL CORPORATION profit loss from operating activities for the quarter ending 2021-12-31 was -$2.80M.
- NYMOX PHARMACEUTICAL CORPORATION profit loss from operating activities for the quarter ending 2021-09-30 was -$3.29M.
- NYMOX PHARMACEUTICAL CORPORATION profit loss from operating activities for the quarter ending 2021-06-30 was -$3.98M.
- NYMOX PHARMACEUTICAL CORPORATION profit loss from operating activities for the quarter ending 2021-03-31 was -$2.43M.
| Period end | Profit Loss From Operating Activities 3 month | Profit Loss From Operating Activities 6 month | Profit Loss From Operating Activities 9 month | Profit Loss From Operating Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$4.28M 20-F · filed 2025-06-03 | |||
| 2023-12-31 | -$8.35M 20-F · filed 2025-06-03 | |||
| 2022-12-31 | -$6.65M 20-F · filed 2025-06-03 | |||
| 2021-12-31 | -$2.80M derived: 20-F 12 month − 6-K 9 month · filed 2024-08-29 | -$6.10M derived: sum of 2 quarters · filed 2024-08-29 | -$10.08M derived: sum of 3 quarters · filed 2024-08-29 | -$12.50M 20-F · filed 2024-08-29 |
| 2021-09-30 | -$3.29M 6-K · filed 2021-11-12 | -$7.27M derived: sum of 2 quarters · filed 2021-11-12 | -$9.70M 6-K · filed 2021-11-12 | -$11.72M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-06-30 | -$3.98M 6-K · filed 2021-08-13 | -$6.41M 6-K · filed 2021-08-13 | -$8.42M derived: sum of 3 quarters · filed 2023-05-02 | -$12.57M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-03-31 | -$2.43M 6-K · filed 2021-05-14 | -$4.44M derived: sum of 2 quarters · filed 2023-05-02 | -$8.59M derived: sum of 3 quarters · filed 2023-05-02 | -$11.52M derived: sum of 4 quarters · filed 2023-05-02 |
| 2020-12-31 | -$2.02M derived: 20-F 12 month − 6-K 9 month · filed 2023-05-02 | -$6.16M derived: sum of 2 quarters · filed 2023-05-02 | -$9.09M derived: sum of 3 quarters · filed 2023-05-02 | -$11.72M 20-F · filed 2023-05-02 |
| 2020-09-30 | -$4.14M 6-K · filed 2021-11-12 | -$7.07M derived: sum of 2 quarters · filed 2021-11-12 | -$9.71M 6-K · filed 2021-11-12 | -$12.41M derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-06-30 | -$2.93M 6-K · filed 2021-08-13 | -$5.56M 6-K · filed 2021-08-13 | -$8.27M derived: sum of 3 quarters · filed 2022-03-30 | -$10.77M derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-03-31 | -$2.63M 6-K · filed 2021-05-14 | -$5.34M derived: sum of 2 quarters · filed 2022-03-30 | -$7.84M derived: sum of 3 quarters · filed 2022-03-30 | -$13.04M derived: sum of 4 quarters · filed 2022-03-30 |
| 2019-12-31 | -$2.71M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-30 | -$5.21M derived: sum of 2 quarters · filed 2022-03-30 | -$10.41M derived: sum of 3 quarters · filed 2022-03-30 | -$13.32M 20-F · filed 2022-03-30 |
| 2019-09-30 | -$2.51M 6-K · filed 2020-11-13 | -$7.71M derived: sum of 2 quarters · filed 2020-11-13 | -$10.62M 6-K · filed 2020-11-13 | -$13.37M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | -$5.20M 6-K · filed 2020-08-14 | -$8.11M 6-K · filed 2020-08-14 | -$10.87M derived: sum of 3 quarters · filed 2021-03-29 | -$13.68M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | -$2.91M 6-K · filed 2020-05-14 | -$5.67M derived: sum of 2 quarters · filed 2021-03-29 | -$8.48M derived: sum of 3 quarters · filed 2021-03-29 | -$10.90M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | -$2.75M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-29 | -$5.56M derived: sum of 2 quarters · filed 2021-03-29 | -$7.98M derived: sum of 3 quarters · filed 2021-03-29 | -$10.64M 20-F · filed 2021-03-29 |
| 2018-09-30 | -$2.81M 6-K · filed 2019-11-13 | -$5.23M derived: sum of 2 quarters · filed 2019-11-13 | -$7.89M 6-K · filed 2019-11-13 | -$11.20M derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-06-30 | -$2.42M 6-K · filed 2019-08-14 | -$5.08M 6-K · filed 2019-08-14 | -$8.39M derived: sum of 3 quarters · filed 2020-03-30 | -$12.95M derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-03-31 | -$2.66M 6-K · filed 2019-05-15 | -$5.97M derived: sum of 2 quarters · filed 2020-03-30 | -$10.53M derived: sum of 3 quarters · filed 2020-03-30 | -$13.13M derived: sum of 4 quarters · filed 2020-03-30 |
| 2017-12-31 | -$3.31M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-30 | -$7.88M derived: sum of 2 quarters · filed 2020-03-30 | -$10.47M derived: sum of 3 quarters · filed 2020-03-30 | -$13.23M 20-F · filed 2020-03-30 |
| 2017-09-30 | -$4.57M 6-K · filed 2018-11-13 | -$7.16M derived: sum of 2 quarters · filed 2018-11-13 | -$9.93M 6-K · filed 2018-11-13 | |
| 2017-06-30 | -$2.60M 6-K · filed 2018-08-13 | -$5.36M 6-K · filed 2018-08-13 | ||
| 2017-03-31 | -$2.76M 6-K · filed 2018-05-15 | |||
| 2016-12-31 | -$12.87M 20-F · filed 2019-03-29 | |||
| 2015-12-31 | -$17.66M 20-F · filed 2018-03-30 |